INS and type 2 diabetes mellitus: While there have been older reports of improved HbA1c levels following SMBG among non-insulin treated T2DM patients [15-16], more recent systematic reviews have since found either non-statistically significant changes in glycaemic control [17] or very limited demonstrable clinical benefit [18-20].